Tissue plasminogen activator; identifying major barriers related to intravenous injection in ischemic acute cerebral infraction

BACKGROUND: According to previous publications, in patients with acute ischemic cerebral infarction, thrombolytic therapy using intravenous tissue plasminogen activator (IV-tPA) necessitates precise documentation of symptoms’ onset. The aim of this study was to identify major barriers related to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Khorvash, Fariborz, Heidary, Fatemeh, Saadatnia, Mohammad, Chitsaz, Ahmad, Tolou-Ghamari, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367212/
https://www.ncbi.nlm.nih.gov/pubmed/28458710
http://dx.doi.org/10.4103/1735-1995.200318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367212/
https://www.ncbi.nlm.nih.gov/pubmed/28458710
http://dx.doi.org/10.4103/1735-1995.200318

Ejemplares similares